Acasti Pharma Inc.
(NASDAQ:ACST)
$2.30
-0.01 (-0.43%)
Open: 1:09 PM
ACST Stock Price Graph
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- YTD
- All
ACST Stock Price Today
Acasti Pharma Inc. (ACST) stock declined over -1.29% intraday to trade at $2.3 a share on NASDAQ. The stock opened with a gain of 3.86% at $2.42 and touched an intraday high of $2.49, falling -1.29% against the last close of $2.33. The Acasti Pharma Inc. in stock market went to a low of $2.32 during the session.
ACST Stock Snapshot
$2.33
Prev. Close
21.62 Million
Market Cap
$2.32
Day Low
$2.42
Open
N/A
Number of Shares
$2.49
Day High
N/A
P/E ratio
-5.41
EPS (TTM)
2.87
Cash Flow per Share
N/A
Free Float in %
7.10
Book Value
7430.00
Volume
ACST Stock Price History Chart
| Date | Open | High | Low | Close | Volume |
|---|
Contact Details
3009 boulevard de la Concorde EastLaval, QC H7E 2B5CA
Website:https://www.acastipharma.com
Contact #:450 687 2262
Company Information
EmployeesN/A
Beta1.44
Sales or RevenueN/A
5Y Sales Change-20.00%
Fiscal Year EndsMar. 2023
SectorHealthcare
IndustryBiotechnology
About Company
Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
Peers
Frequently Asked Questions
What is the current Acasti Pharma Inc. (ACST) stock price?
Acasti Pharma Inc. (NASDAQ: ACST) stock price is $2.30 in the last trading session. During the trading session, ACST stock reached the peak price of $2.49 while $2.32 was the lowest point it dropped to. The percentage change in ACST stock occurred in the recent session was -1.29% while the dollar amount for the price change in ACST stock was -$0.03.
ACST's industry and sector of operation?
The NASDAQ listed ACST is part of Biotechnology industry that operates in the broader Healthcare sector. Acasti Pharma Inc. , a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases.
Who are the executives of ACST?
Dr. Yves Lachance Ph.D.
Vice President of Quality & Compliance
Ms. Janelle D'Alvise
Pres, Chief Executive Officer, Corporation Sec. & Director
Dr. Pierre Lemieux M.D., Ph.D.
Co-Founder, Chief Operating Officer & Chief Scientific Officer
Ms. Christine Pelletier CHRP
Senior Director of HR
How ACST did perform over past 52-week?
ACST's closing price is 0.29% higher than its 52-week low of $1.72 where as its distance from 52-week high of $5.04 is -0.59%.
How many employees does ACST have?
Number of ACST employees currently stands at N/A. ACST operates from 3009 boulevard de la Concorde East, Laval, QC H7E 2B5, CA.
Link for ACST official website?
Official Website of ACST is: https://www.acastipharma.com
How do I contact ACST?
ACST could be contacted at phone #450 687 2262 and can also be accessed through its website. ACST operates from 3009 boulevard de la Concorde East, Laval, QC H7E 2B5, CA.
How many shares of ACST are traded daily?
ACST stock volume for the day was 7430.00 shares. The average number of ACST shares traded daily for last 3 months was 50.76 Thousands.
What is the market cap of ACST currently?
The market value of ACST currently stands at $21.62 Million with its latest stock price at $2.30 and N/A of its shares outstanding.